HIV's impact in Zimbabwe explored in new researchAugust 28, 2007The impact of HIV in Zimbabwe since the early 1980s is explored in new research published this week in the journal PNAS. Researchers found that HIV's impact on Zimbabwe's population as a whole has not been quite as severe as some predicted in 1989, when a group of epidemiologists at a World Health Organisation meeting modelled its potential effects. Some of the models they created suggested that the population of Zimbabwe might start shrinking, with more people dying than being born. The new research shows that the population of the country continues to grow. However, in the worst affected areas, HIV has reduced the level of population growth by two thirds, from 2.9% to 1.0% each year.
The study is the first to look in detail at the demographic impact of HIV in Zimbabwe. The researchers, from Imperial College London and the Biomedical Research and Training Institute in Harare, focus on an area in the Manicaland region in the east of Zimbabwe over the period 1998 - 2005. They show that the crude death rate was double what it would have been in the absence of HIV and the birth rate was somewhat lower. The death rate was approximately three times higher in the towns and estates, and twice as high in the villages, as it would have been without HIV. Amongst those aged 15-54, approximately one person in every three in towns (32.8%), and one person in every five in the estates (22.2%) and villages (17.3%) had HIV. Dr Simon Gregson, the lead author of the study from the Department of Infectious Disease Epidemiology at Imperial College London, said: "As in other parts of Africa, HIV has had a devastating effect on the lives of people in Zimbabwe. However, our research shows that, in spite of countless people having lost their lives to the virus, more people are still being born than are dying. The prevalence of HIV has been coming down in the last few years and, as more people receive treatment, we hope the death rate will soon also start to go down." Imperial College London | |||||||||||||||||||||
|
Related HIV Current Events and HIV News Articles More at-risk teens and young adults engaging in anal intercourse A new study by researchers at the Bradley Hasbro Children's Research Center suggests that the incidence of heterosexual anal sex is increasing among teens and young adults - particularly those who have recently had unprotected vaginal sex. Landmark study defines benefits of early HIV testing and treatment for infected infants Testing very young babies for HIV and giving antiretroviral therapy (ART) immediately to those found infected with the virus dramatically prevents illness and death, according to a report in the New England Journal of Medicine. Stopping germs from ganging up on humans Keeping germs from cooperating can delay the evolution of drug resistance more effectively than killing germs one by one with traditional drugs such as antibiotics, according to new research from The University of Arizona in Tucson. First Holistic Guide to Primate Disease Covers Critical Gap in Global Health Why are so many infectious diseases jumping from animals to humans? Why do we have so little capacity to predict epidemics, or avoid them? Applying 'supply and demand' business principles to treat infectious diseases worldwide Treating infectious diseases while meeting escalating costs to do so continues to pose worldwide challenges, with one of the main issues being the ability to provide an adequate supply of drugs to treat infectious diseases. New gene silencing pathway found in plants Biologists at Washington University in St. Louis have made major headway in explaining a mechanism by which plant cells silence potentially harmful genes. Study finds Canada's supervised injection facility cost-effective Canada's only supervised injection facility is extending lives and saving the health-care system millions of dollars, a new study shows. Results of landmark study of HIV vaccine published in the Lancet Results from the Step study, a test-of-concept efficacy study of a Merck & Co., Inc. HIV vaccine candidate, were published online today in two papers in The Lancet. These analyses of the Step study are being conducted, presented and published to inform the continued search for an effective HIV vaccine. Who has sex with whom? Study of heterosexual partnerships reveals worryingly low condom use A high proportion of people are not using condoms when they have sex with a new partner, according to a new study of heterosexual partnerships among British men and women. Among people in their 30s and 40s, and in partnerships where there is an age difference of five or more years, condom use is particularly low. Purdue researcher invents molecule that stops SARS A Purdue University researcher has created a compound that prevents replication of the virus that causes SARS and could lead to a treatment for the disease. More HIV Current Events and HIV News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||